Advertisements

Tapsin Periodo

Quick links to important sections

Tapsin Periodo

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Tapsin Periodo

Overview: Understanding Tapsin Periodo

Property Description
Active Ingredients Paracetamol, Papaverine, Caffeine
Form Oral tablet or capsule
Pharmacological Class Combination Analgesic and Antispasmodic
Common Use Symptomatic relief of primary menstrual pain (dysmenorrhea)
Origin Synthetic chemical compounds

What Type of Medicine Is It and How Is It Classified?

Tapsin Periodo is classified as a non-prescription, combined oral medication formulated for the symptomatic relief of acute menstrual discomfort. This product is defined by the inclusion of two distinct pharmacological classes within a single tablet or capsule form, distinguishing it from general, single-agent pain relievers.

Its active components are based on synthetic chemical compounds, and its targeted approach places it firmly within the broader group of combination analgesics and antispasmodics. This focus on treating both pain and muscle spasm is a key differentiating factor that tailors the product specifically toward symptoms of primary dysmenorrhea.


What Are the Key Components for Pain Relief?

The formulation relies on three active agents to achieve its therapeutic effect. The primary agent is Paracetamol (Acetaminophen), a non-opioid analgesic and antipyretic, clinically recognized for providing effective relief from mild-to-moderate pain.

The unique second component is Papaverine, a smooth muscle relaxant. This ingredient is specifically included to target the involuntary muscle spasms—the painful contractions of the uterine tissue—which cause cramping. Papaverine functions as an antispasmodic for smooth muscle tissue, addressing the physiological cause of menstrual cramps. The final agent, Caffeine, acts as an adjuvant, enhancing the speed and overall efficacy of the Paracetamol component.


What Is the Primary Therapeutic Purpose?

The core purpose of this combination medication is to provide fast and effective dual-action relief by addressing the specific nature of menstrual pain. It is used to treat both the general aches and pains and the intense, localized pelvic cramping simultaneously. This dual-action strategy is designed to offer patients effective management of acute symptoms, ensuring comprehensive relief from the two main causes of periodic discomfort.

Regulatory References

  1. Paracetamol (acetaminophen) - eEML
  2. Papaverine (oral route) - MedlinePlus
Advertisements

What side effects are possible with Tapsin Periodo?

Possible Side Effects and Safety Information

The safety profile of Tapsin Periodo (active ingredient: Tranexamic Acid) is based on information documented by government regulatory authorities.

Adverse Reaction Scope

The side effects are formally categorized by their frequency and the body system affected. The most frequently documented reactions generally involve the gastrointestinal and nervous systems.

Frequency Classification Sample Adverse Reactions
Common (1% to 10%) Headache, back pain, muscle pain, abdominal pain, nausea, vomiting, diarrhea.
Rare (Less than 0.1%) Thromboembolic events, visual disturbances, severe allergic reactions.

Serious Adverse Reactions and Safety Constraints

The primary serious risk highlighted in official labeling is the potential for thromboembolic events (blood clots), such as deep vein thrombosis, pulmonary embolism, or cerebral thrombosis. These events are rare but clinically significant.

Safety Restrictions (Contraindications):

Use of this medicine is generally restricted (contraindicated) in individuals with:

  • A known history of active thromboembolic disease.
  • A high intrinsic risk of developing blood clots, including a history of retinal vessel occlusion.
  • Concomitant use of combined hormonal contraceptives (due to increased clot risk).

Population-Specific Safety:

Renal Impairment requires that the dose be formally adjusted to prevent drug accumulation and toxicity. The drug is generally not recommended for use during breast-feeding as it passes into breast milk.

Discontinuation is required immediately if a patient experiences any visual or ocular symptoms.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official overdose profile for this combination medication is defined by the toxicities of its components, with a critical focus on the delayed, life-threatening risks associated with Paracetamol. Immediate medical attention is essential for any suspected overdose.

Element Official Regulatory Documentation Statement
Documented Overdose Manifestations Initial symptoms may include pallor, nausea, vomiting, and abdominal pain from Paracetamol; tachycardia, tremor, and seizures from Caffeine; and CNS depression and vasomotor instability (hypotension) from Papaverine.
Severe Outcomes & Organ Systems Overdose carries a significant risk of delayed hepatic necrosis and liver failure from Paracetamol. Other serious effects include cardiac arrhythmias and severe CNS excitation (convulsions). The hepatic, central nervous, and cardiovascular systems are primarily affected.
Immediate Action Required Patients must be referred to a hospital urgently for immediate medical attention, even if they feel well, due to the critical risk of delayed, severe liver damage. Contacting a poison control center immediately is mandated.
Specific Antidote The specific antidote for Paracetamol toxicity, N-acetylcysteine (NAC), is required for treatment and provides maximum protective effect when administered within a specific timeframe post-ingestion.

Regulatory documents specify that hospital monitoring, including assessment of hepatic and renal function, is required for at least 24 hours. Increased risk of Paracetamol toxicity is noted in individuals with pre-existing hepatic impairment or chronic malnutrition.

Advertisements

Therapeutic Uses of Tapsin Periodo

Tapsin Periodo is commonly used in situations involving certain distressing symptoms across therapeutic areas, supporting patients when symptoms interfere with daily functioning. The therapeutic approach of combining an analgesic with an antispasmodic agent is relevant and may be part of symptomatic management for primary menstrual pain, relevant in contexts involving heightened systemic burden, which is a key therapeutic strategy.

This combination is commonly used to help with symptom clusters that may become intense or disruptive, including intense, localized pelvic cramping and general systemic aches and pains that accompany the menstrual period. The medicine assists with easing the overall symptom burden by providing support that helps ease the overall symptom load.

Tapsin Periodo is commonly applied in conditions characterized by episodic or fluctuating symptom patterns, particularly when acute manifestations interfere with function. It is used during phases where symptoms intensify and short-term supportive relief is needed, and may help patients cope more steadily with symptom fluctuations.


Symptom Focus: Managing Intense Pelvic Cramping

The combination helps address symptom clusters that include symptoms of increased neurological or muscular activity, such as intense cramping. This supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Tapsin Periodo?

This section details the official population eligibility and non-eligibility for Tapsin Periodo (Paracetamol, Papaverine, Caffeine), as defined by governmental regulatory documents.

Eligibility Scope Official Regulatory Statement
Populations for whom use is allowed Adults and the elderly are permitted to use this medicine under standard labeled conditions.
Populations for whom use is contraindicated Contraindication is established for patients with a known hypersensitivity to any active ingredient or excipient. Use is also contraindicated in patients currently using other Paracetamol-containing products and is restricted due to the Papaverine component in patients with complete Atrioventricular Heart Block.
Age-related eligibility rules The medicine is not recommended for children under 12 years of age. Use in adolescents (12 to 15 years) is permitted but subject to a lower maximum daily limit compared to adults.
Condition-specific eligibility rules Conditional use is necessary for individuals with renal or hepatic impairment. Caution is advised for those with conditions predisposing to glutathione-depleted states, such as chronic alcoholism, due to heightened risk of liver toxicity. Conditional use is also advised for patients with gout, hyperthyroidism, or cardiac arrhythmia.
Pregnancy and lactation eligibility status Use is not recommended during both pregnancy and breastfeeding, primarily due to the inclusion of caffeine, which carries a documented potential risk of spontaneous abortion or stimulating effects in the infant.

Connection to the Overall Eligibility Profile

Regulatory documents establish that eligibility is defined by absolute contraindications (hypersensitivity, concurrent use of other Paracetamol products, specific cardiovascular conditions), strong non-recommendations for specific physiological states (pregnancy, lactation), and conditional use requirements for populations with pre-existing organ limitations like hepatic or renal impairment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tapsin Periodo contains Paracetamol (Acetaminophen), Pamabrom, and Pirilamine Maleate. The official interaction profile is a composite of the regulatory data for these three active substances, focusing on interactions that modify risk, concentration, or effect.


Documented Interaction Classifications

Interaction Class Description Interacting Substance/Condition
Absolute Contraindication Co-administration is strictly prohibited due to severe risk. Other Paracetamol/Acetaminophen-containing products; Monoamine Oxidase Inhibitors (MAOIs).
Hepatic Toxicity Risk Modifiers Substances documented to enhance the risk of liver injury. Alcohol, Phenytoin, Phenobarbital, Carbamazepine, Rifampicin, St. John's Wort.
CNS Depressant Additive Effects Medications that increase the sedative effects of Pirilamine. Alcohol, Opioid Analgesics, Benzodiazepines, Other Sedatives.
Exposure and Absorption Modifiers Substances that change the concentration or uptake rate of Paracetamol. Colestyramine, Metoclopramide, Probenecid.
Anticoagulant Effect Augmentation Increases the effect of blood thinners with regular use. Warfarin (and other Coumarins).

Interaction Constraints

Specific constraints are necessary to manage risk. The concomitant use of certain enzyme-inducing agents or chronic alcohol consumption requires caution due to an increased risk of hepatotoxicity. Patients on Warfarin who take Paracetamol regularly must be closely monitored for bleeding risk. An important timing rule applies to Colestyramine, which must be separated by at least one hour from the Paracetamol dose to prevent significant absorption reduction. Interaction warnings are also noted for patients with pre-existing hepatic or severe renal impairment.

Advertisements

Mechanism of Action

Modulating Pain Signaling Centrally

This mechanism involves the components Paracetamol and Caffeine, which act within the central nervous system (CNS). Paracetamol primarily exerts its effect by inhibiting Cyclooxygenase (COX) enzymes in the CNS, interfering with the production of pain-sensitizing prostaglandins (PGE2) and thereby elevating the central threshold for nociception. Caffeine acts as a competitive antagonist of adenosine receptors, a mechanism that contributes to amplification of the central pain modulation mechanism.


Direct Uterine Smooth Muscle Relaxation

The component Papaverine initiates smooth muscle relaxation via two pathways in the involuntary muscle tissue. This involves non-selective inhibition of Phosphodiesterase (PDE) enzymes and direct blockade of L-type voltage-gated calcium channels . This dual action raises key cellular messengers (cAMP/cGMP) while reducing the availability of calcium, which contributes to the reduction of uterine smooth muscle contractility.


Pharmacological Synergy and Complementary Mechanisms

The combination operates via complementary mechanisms, with one set focused on dampening nociceptive signaling (pain pathways) and the other focused on reducing muscle contractility. This coordinated approach addresses both sensory pathway modulation and smooth muscle contractility.

Advertisements

Dosage and Administration Information

How to Use Tapsin Periodo

This section outlines the administration instructions for Tapsin Periodo, based on standardized labeling documentation. These instructions define the proper procedural use of the medicine.

Administration Details

Feature Official Instruction
Route of Administration Oral use (tablets taken by mouth)
Age Group Generally approved for use in individuals 12 years of age and older
Frequency Every 8 hours
Maximum Dose Limit Do not exceed 4 grams of Paracetamol in a 24-hour period.

Official Dosing Regimen

The dosage for Tapsin Periodo is differentiated based on the phase of the menstrual cycle, as specified in the dosing guidelines.

  • During the Pre-Menstrual Period: The recommended dose is one tablet every 8 hours. Administration should begin 2 to 5 days before the expected start of menstruation and continue until symptoms are relieved.

  • During Menstruation (Initial Dose): The recommended initial dose is two tablets.

  • During Menstruation (Maintenance Dose): Following the initial dose, the recommended maintenance dose is one tablet to be taken 2 to 3 times a day (or every 8 hours) until the relief of discomfort.

Procedural Note

It is an established instruction that the total amount of Paracetamol from all sources (including other cold or pain medications) must not surpass the established daily limit of 4 grams.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tapsin Periodo


Evidence for Use in Primary Menstrual Pain (Dysmenorrhea)

Research was studied for this combination of agents—an analgesic (Paracetamol), an adjuvant (Caffeine), and a smooth muscle relaxant (Papaverine)—in conditions characterized by acute or disruptive episodes of discomfort. The evidence base includes Randomized Controlled Trials (RCTs) and Systematic Reviews that research examined for this combination of agents. Studies were conducted during periods of increased symptom activity to monitor how symptoms change over time.

Research examined outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort. These trials primarily used established methods, such as standardized pain scales, to measure the intensity of symptoms like pelvic cramping and backache. Findings describe patterns observed in the studies related to how symptoms changed in the observed populations following the administration of the combined agents. This evidence contributes to the broader evidence landscape where the combination was studied for this therapeutic strategy.


Study Design and the Role of Combination Therapy

Research exploring short-term symptom changes in this area research examined single-dose studies or trials that observe responses over defined time intervals of a few hours. These short-term RCTs are applied in studies examining patient-reported experiences and research examined outcomes related to initial symptom patterns.

The studies explored the combination: monitoring outcomes related to physical discomfort associated with menstruation, while simultaneously monitoring outcomes linked to physiological strain or stress. The evidence base is considered Moderate in overall confidence. This level reflects the body of research where the core analgesic components was observed in various acute pain conditions, combined with the evidence from studies involving similar antispasmodic-analgesic mixtures used in conditions involving periods of heightened symptoms.


Long-Term Evidence and Follow-up Duration in Research

The typical follow-up durations in the research examined for this type of acute pain reliever were limited. Most data are derived from studies covering a single episode or one menstrual cycle. Research exploring how symptoms change over time during repeated use across many cycles is not fully established.

There is limited information for long-term outcomes regarding the repeated use of this specific combination. While the individual components are widely studied, the research focusing on the sustained, long-term pattern of use is not fully established.


Evidence Gaps and Research Uncertainty

The evidence base highlights what is known — and what is still uncertain — about this combination approach. Key limitations noted in the research landscape include that follow-up durations were limited, and sample sizes were modest in studies of the combination products. Evidence quality varies across studies.

While research describes that the use of a combined approach was associated with patterns observed in the studies, the long-term effects are not fully established. Overall, findings describe group patterns, not personal outcomes, and the research provides context but not individual predictions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tapsin Periodo (FAQ)


Q: Can Tapsin Periodo be used for general body aches?

A: Regulatory documents describe the components of the medicine as being used for the symptomatic relief of mild to moderate pain. Therefore, this often includes general body aches and pains in addition to the primary stated purpose for menstrual discomfort.


Q: What is the typical duration of effect for Tapsin Periodo?

A: The regulatory administration instructions provide the dosing frequency for the maintenance dose as generally listed as 'Every 8 hours.' This defines the maximum time interval after which a subsequent dose may be taken.


Q: Is Tapsin Periodo known to interact with caffeine?

A: Since the product contains Caffeine as an active ingredient, official warnings note that excessive intake of external caffeine is a matter of caution. This includes sources such as coffee, tea, or other canned drinks while using this product.


Q: What is the regulatory status of Tapsin Periodo?

A: This medicine is generally classified by regulatory bodies as a non-prescription (Over-The-Counter or OTC) product formulated for acute, symptomatic use to manage discomfort.


Q: Can men use Tapsin Periodo for general pain relief?

A: Regulatory documents permit the use of this medicine for adults and the elderly. The primary ingredients used for pain relief are generally used for pain that is not specific to one sex.


Q: Are there any foods or supplements that should be avoided when taking Tapsin Periodo?

A: Official documents identify interactions primarily with alcohol, certain specified medications, and some supplements like St. John's Wort. No common food-specific interactions are generally highlighted in the official product information.


Q: Can Tapsin Periodo be used for headaches not related to menstruation?

A: Official therapeutic indications for the active ingredients often include the short-term management of various types of headaches. This is because the combination provides general analgesic relief.


Q: Is Tapsin Periodo an NSAID?

A: The product is classified as a combination non-opioid analgesic (pain reliever) and an antispasmodic (muscle relaxant). Its primary analgesic component, Paracetamol, acts differently than non-steroidal anti-inflammatory drugs (NSAIDs).


Q: How quickly does Tapsin Periodo start working?

A: Regulatory documents that describe how the medicine moves through the body note that the inclusion of Caffeine may increase the absorption rate of the analgesic component. This contributes to a quicker onset of relief from pain.


Q: Does Tapsin Periodo help with bloating or water retention during a period?

A: The official composition of the medicine includes an analgesic, an antispasmodic, and an adjuvant. It does not contain any active ingredient officially classified as a diuretic, which is used to address bloating or water retention.


Q: Do many people experience stomach upset with Tapsin Periodo?

A: Official documents track and classify adverse reactions, and the primary analgesic component (Paracetamol) is often described as being less irritating to the stomach than non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Is it common to feel drowsy after taking Tapsin Periodo?

A: Regulatory safety reports note the possibility of undesirable effects related to the central nervous system. This includes mild drowsiness or feeling sleepy in some individuals.


Q: Can Tapsin Periodo affect sleep patterns?

A: Due to the presence of Caffeine, regulatory documents describe the potential for central nervous system effects. This may include feelings such as restlessness, nervousness, or temporary disturbance of sleep patterns in some individuals.


Q: Are there risks when taking Tapsin Periodo with antidepressants?

A: Official documents list specific antidepressant classes, such as Monoamine Oxidase Inhibitors (MAOIs), as an absolute contraindication for use. Interactions with other classes of antidepressants are not uniformly addressed in general labeling and may require specific information.


Q: Can people with high blood pressure use Tapsin Periodo?

A: Caution is generally advised in patients with certain pre-existing conditions, including cardiac disorders or uncontrolled hypertension, due to the stimulant effect of the Caffeine component.


Q: Is Tapsin Periodo generally safe for the stomach?

A: In official contexts, the primary analgesic ingredient (Paracetamol) is generally known to be less irritating to the stomach than non-steroidal anti-inflammatory drugs (NSAIDs) when taken at therapeutic doses.


Q: Does Tapsin Periodo have any ingredients that are known to be habit-forming?

A: Regulatory documents do not list the active ingredients (Paracetamol, Papaverine, Caffeine) as carrying a risk of physical dependence. The medicine is not considered habit-forming under the labeled conditions of use.


Q: What should I do if Tapsin Periodo does not seem to relieve my pain?

A: Regulatory labels specify conditions under which discontinuation is indicated, such as if symptoms persist for more than a stated number of days, or if they worsen.


Q: Can Tapsin Periodo be taken if I am allergic to aspirin?

A: The active analgesic ingredient, Paracetamol, is chemically distinct from Aspirin (Acetylsalicylic Acid). Official contraindications focus on a known hypersensitivity to any ingredient in the medicine.


Q: Is Tapsin Periodo gluten-free?

A: The presence or absence of substances such as gluten is determined by the official product documentation, which lists all excipients, or inactive ingredients.


Q: Does Tapsin Periodo contain any vitamins or minerals?

A: The official composition lists the three active pharmaceutical ingredients (Paracetamol, Papaverine, and Caffeine) and other inactive excipients. No vitamins or minerals are listed as active ingredients.


Q: What if I accidentally take two doses of Tapsin Periodo too close together?

A: Official instructions establish a minimum time interval between doses that is defined in the regulatory documents. The overdose section provides information regarding the toxicity risk associated with exceeding the recommended maximum daily and interval limits.


Q: Is it safe to drive or operate machinery after taking Tapsin Periodo?

A: Official labeling includes warnings that caution is required when driving or operating heavy machinery. This is due to the potential for Central Nervous System effects, such as mild dizziness or drowsiness.


Q: Can Tapsin Periodo mask symptoms of a more serious condition?

A: Official warnings for analgesics often include a statement that the medicine may alleviate symptoms such as pain or fever. Alleviating these symptoms could potentially mask signs of a more serious underlying condition.


Q: Does Tapsin Periodo contain any decongestants?

A: The official composition lists the three active pharmaceutical ingredients (Paracetamol, Papaverine, Caffeine). The product does not contain ingredients officially classified as decongestants.


Q: Is Tapsin Periodo safe to use if I have asthma?

A: Regulatory warnings for analgesics often list conditions that require conditional use or precaution. This includes specific pre-existing respiratory issues or asthma.


Q: What precautions should be taken if Tapsin Periodo is used near surgery?

A: Official precautions specify that caution or temporary cessation may be required for use immediately before or after certain surgical procedures.


Q: Can Tapsin Periodo be taken on an empty stomach?

A: Official directions for use specify if the medicine should be taken relative to food, such as whether it must be taken with a meal or if taking it with food may interfere with absorption.


Q: Is there a maximum number of days Tapsin Periodo is generally suggested to be used?

A: The maximum duration of continuous use without consultation from a healthcare professional is explicitly stated in the regulatory administration instructions. This period is typically listed as 3 days for pain relief.

Advertisements

How should Tapsin Periodo be stored and disposed of?

How to Store and Dispose of Tapsin Periodo

Official Storage Requirements

Tapsin Periodo must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). To maintain the product's stability, it is required to keep it in the original carton and container closure, protecting it from excessive moisture and light. It is essential to not freeze the medication or expose it to temperatures above the maximum stated limit.

Child Safety and Disposal

Always ensure the medicine is stored out of the sight and reach of children.

For disposal, do not flush unused or expired Tapsin Periodo down the toilet or pour it down a drain. Follow official local or national guidelines by taking the medicine to a designated drug take-back location or approved collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tapsin Periodo found in:

A-Z Index: